Abstract:Using highly focused revolving radiation beams, stereotactic body radiation therapy (SBRT) can focus on tumor sites while minimizing the irradiation to the surrounding normal tissues, which is different from traditional radiotherapy. Although it may cause difficult to manage toxicity, such as stenosis, ulceration, fibrosis, and even necrosis sometimes, it holds advantages such as high accuracy, noninvasiveness, and convenient outpatient treatment. Similarly, Tumor ablation has been widely used in the clinical treatment of cancer because of its advantages of minimal invasiveness, high operability, and good repeatability. The most commonly used ablation methods are microwave ablation (MWA), radiofrequency ablation (RFA) and cry ablation, among which MWA and RFA belong to thermal ablation. In addition, irreversible electroporation may play an increasing role in the treatments of solid tumors. Stereotactic body radiation therapy, developed from stereotactic radiosurgery in the treatment of brain and spinal lesion, is commonly used in the treatment of early peripheral lung cancer and is increasingly used in the treatment of other primary or metastatic tumors. Many studies were done to explore its application in early nonsmall-cell lung cancer. Halperm et al compared the toxicities and cost of proton radiation, intensity-modulated radiotherapy (IMRT), and SBRT among younger men with prostate cancer. They showed that SBRT and IMRT had similar toxicity, but SBRT was cheaper than IMRT. de Geus et al evaluated the impact of SBRT on survival of patients with unresectable pancreatic cancer. Compared to chemotherapy alone or chemotherapy in combination with traditional fractionated external-beam radiotherapy, SBRT had a survival advantage. These results support SBRT as a promising treatment for patients with unresectable pancreatic cancer. Lazzari et al evaluated SBRT for patients with metachronous oligometastatic ovarian cancer in reference to local control, toxicity, delay of systemic treatment, and survival outcomes. Results showed good local control with a favorable toxicity profile. Altogether, SBRT may be an attractive option for some cancers in specific clinical scenarios. Ablation techniques have also made great progress in the treatment of solid tumors in recent years. For very early and early stage hepatocellular carcinoma (HCC), RFA has been recommended as a feasible alternative to surgical resection and liver transplantation. For HCC 2 cm, RFA combined with chemoembolization can contribute to near-curative therapy. A Markov modeling study conducted by Pollom et al showed that SBRT for initial treatment of localized, inoperable HCC was not cost-effective compared to RFA. However, SBRT is the preferred salvage therapy for local progression after RFA. Rajyaguru et al analyzed the National Cancer Database and drew similar conclusions. In a study by Zhuo et al, ultrasonographically-guided MWA was effective and safe for managing secondary hyperparathyroidism (SHPT) glands, providing rationale to use MWA for an alternative therapy for patients who are unable or refuse to undergo parathyroidectomy refractory or for patients having drug-resistant SHPT. Irreversible electroporation is a new tumor ablation technique that uses a pulsed electric field to create irreversible nanoscale pores on the cell membrane, thereby killing tumor cells. It has been attempted in liver tumor, pancreatic tumor, renal tumor, among others. Furthermore, immunomodulatory drugs have the potential to enhance systemic anticancer immune effects induced by local thermal ablation, and several studies have investigated strategies for combining immunoadjuvants with thermal ablation to stimulate stronger

Activation of local and systemic anti-tumor immune responses by ablation of solid tumors with intratumoral electrochemical or alpha radiation treatments

Tumor abolition and antitumor immunostimulation by physico-chemical tumor ablation

The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules

Therapeutic Effects Of Ablative Radiation On Local Tumor Require Cd8(+) T Cells: Changing Strategies For Cancer Treatment

Immunological effect of local ablation combined with immunotherapy on solid malignancies

Stereotactic Body Radiation Therapy and Ablative Therapies for Solid Tumors: Recent Advances and Clinical Applications

Immune Responses and Anti-Tumor Effects after Radiofrequency Ablation Therapy in Tumor Patients

Novel Immune Stimulant Amplifies Direct Tumoricidal Effect of Cancer Ablation Therapies and Their Systemic Antitumor Immune Efficacy

History, Principles, and Techniques of Radiofrequency Ablation

Present and future of metal nanoparticles in tumor ablation therapy.

High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity

Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade

Tumor Thermal Ablation Therapy Using Alkali Metals As Powerful Self-Heating Seeds.

Localized ablative immunotherapy drives de novo CD8 + T-cell responses to poorly immunogenic tumors

Comparative study of immune response to local tumor destruction modalities in a murine breast cancer model

A new local ablation for solid malignant tumours: Anti-tumour effect of hyperthermal and electrochemical therapy on transplantable mouse cancer

Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers

Anti-Tumor Effect Of Sodium-Induced Thermochemical Ablation Therapy

Minimally Invasive Injectable Thermochemical Ablation Therapy of Malignant Tumor via Alkali Metal Fluid

Utilization of High-Frequency Irreversible Electroporation (H-FIRE) to modulate the tumor microenvironment and promote systemic immune system activation in breast cancer

Thermal ablation in cancer